Boehringer Ingelheim and The University of Texas Arlington are sponsoring a competition to award one Innovation Prize at BioLabs Pegasus Park.
The Innovation Prize provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate an early-stage startup that is focused on new target concepts or drug discovery in any therapeutic indication. CROs, diagnostics, instrument development and health-IT are excluded. ​
Application Process
The official application process can be found below. Please read and verify your availability before submitting your application.
Innovation Prize Benefits
.png)
Eligibility Snapshot
Boehringer Ingelheim is looking for biotech companies that meet the following criteria:
-
Applicants must be founded and have their principal place of business in Texas, preferably in the Dallas area and willing to occupy BioLabs Pegasus Park.
-
Applicant cannot be capitalized over $2 million.
-
Applicant must not have a partnership with one of the top 20 pharma companies based on annual revenue.
-
Applicants must be focused on new target concepts or drug discovery in any therapeutic indication.
-
Please note that CROs, diagnostics, instrument development, and health-IT companies are not eligible to participate in this competition.
The Application Process
01
Submit the online application by September 30, 2024
02
A subset of applications will be identified as finalist by the contest judges by
October 9, 2024
03
Winning teams will present their company & scientific concept at an in-person event on
October 30, 2024
04
One Innovation Prize will be granted
Good luck!
Contact Us
If you have any questions about BioLabs contact:
If you have any questions about Boehringer Ingelheim contact:
susan.davidson@boehringer-ingelheim.com
​
